Search results for "Highlights"
Diabetes incidence projected to increase among youth in U.S.
A modeling study using data from 2002-2017 found that incidence of type 1 and type 2 diabetes could increase in those under age 20 years by up to 65% and 673%, respectively, over the next three decades, although confidence intervals were wide.
https://diabetes.acponline.org/archives/2023/01/13/1.htm
13 Jan 2023
HbA1c-based screening of general population reduced time to diabetes diagnosis
In a British database, 1% of participants ages 40 to 70 years had undiagnosed diabetes. Researchers estimated that population-based screening using HbA1c level could have reduced the time to diagnosis in this group by a median of 2.2 years.
https://diabetes.acponline.org/archives/2022/12/09/2.htm
9 Dec 2022
Updated guideline on managing hyperosmolar hyperglycemic state issued by U.K. experts
The recommendations from the Joint British Diabetes Societies for Inpatient Care Group cover clinical assessment and monitoring, interventions, and assessments and prevention of harm, as well as five phases of therapy.
https://diabetes.acponline.org/archives/2022/12/09/3.htm
9 Dec 2022
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
Annual screening for albuminuria may not be necessary in all patients with type 1 diabetes
A recent study found that personalizing the timing of testing based on patients' albumin excretion rate and HbA1c level could reduce time with undetected kidney disease as well as testing frequency.
https://diabetes.acponline.org/archives/2022/11/11/2.htm
11 Nov 2022
Diabetes and prior CVD may no longer carry equivalent cardiovascular risk
In a population-based Canadian study, the magnitude of the association between diabetes and risk of cardiovascular events decreased while that between cardiovascular disease (CVD) and such events remained stable.
https://diabetes.acponline.org/archives/2022/11/11/3.htm
11 Nov 2022
Self-monitoring of blood glucose reduced HbA1c in noninsulin-treated patients
Self-monitoring of blood glucose 8 to 11 times a week was more effective than doing so more or less frequently, according to a new meta-analysis.
https://diabetes.acponline.org/archives/2022/12/09/1.htm
9 Dec 2022
ADA, KDIGO offer consensus statements on managing diabetes and chronic kidney disease
The American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) provided specific advice on use of metformin, sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1 receptor agonists, and nonsteroidal mineralocorticoid receptor antagonists in patients with diabetes and chronic kidney disease.
https://diabetes.acponline.org/archives/2022/10/14/1.htm
14 Oct 2022
Time-restricted eating may help improve metabolic status
People who time-restricted their eating had decreased body weight and fat mass and improved lipid values but did not show improvements in waist circumference, HbA1c level, or blood pressure, a systematic review and meta-analysis found.
https://diabetes.acponline.org/archives/2022/10/14/2.htm
14 Oct 2022
Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find
A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://diabetes.acponline.org/archives/2022/10/14/8.htm
14 Oct 2022